Kathmandu Marketing AND Trading Pharmaceutical Import Profile — Nepal (DGFT 2022–2026)

Name: Kathmandu Marketing AND Trading Pharmaceutical Import Records from India — 2 Products, $1.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Kathmandu Marketing AND Trading — Pharmaceutical Importer Profile (2026) | 2 Products, $1.7M Trade | TransData Nexus

Kathmandu Marketing AND Trading

Pharmaceutical Importer · Nepal · Brand Names & OTC Products Focus · $1.7M Total Trade · DGFT Verified

Kathmandu Marketing AND Trading is a pharmaceutical importer based in Nepal with a total trade value of $1.7M across 2 products in 1 therapeutic categories. Based on 217 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Kathmandu Marketing AND Trading sources from 3 verified Indian suppliers, with Reckitt Benckiser (india) Private Limited accounting for 57.6% of imports.

Kathmandu Marketing AND Trading — Import Portfolio & Supplier Network

Kathmandu Marketing AND Trading import network — 2 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Kathmandu Marketing AND Trading?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Reckitt Benckiser (india) Private Limited	$1.7M	226	57.6%
Reckitt Benckiser India Private Limited	$1.0M	138	35.2%
Arazi No.980, Arazi No.979, Arazi N

What Formulations Does Kathmandu Marketing AND Trading Import?

Formulation	Value	Ships
Strepsils warm bli jar	$336.7K	44
Moov spray 35GM	$135.8K	18
Moov spray 80GM	$135.5K	11
Moov crm reg	$133.0K	14
Moov ointment 20 GM	$121.9K	14
Dettol antiseptic liquid 60ML	$119.0K	11
Moo crm reg 15GM-new	$116.1K	10
Strepsils orange bli jar	$108.3K	22
Dettol antiseptic liquid	$89.7K	16
Detol plstr jar	$89.1K	7
Dettol antiseptic reg liquid 125 ML	$68.2K	12
Dtt asl reg 550ML	$65.5K	8
Moov spray 50GM	$62.9K	9
Moov spray 35g+15 GM	$55.3K	3
Strepsils orange jar 224s	$50.4K	7

Kathmandu Marketing AND Trading imports 93 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 2 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Moov	Brand Names & OTC Products	$1.1M	124	8.1%	3
2	Dettol	Brand Names & OTC Products	$620.9K	93	7.2%	3

Kathmandu Marketing AND Trading imports 2 pharmaceutical products across 1 categories into Nepal totaling $1.7M.

Kathmandu Marketing AND Trading — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Kathmandu Marketing AND Trading is a pharmaceutical importer and buyer based in Kathmandu, Nepal. The company specializes in importing finished pharmaceutical formulations, including tablets, capsules, syrups, and injections, primarily from India. With a total import value of $1.7 million USD and 217 shipments, Kathmandu Marketing AND Trading plays a significant role in Nepal's pharmaceutical distribution network. The company's portfolio is highly concentrated, with its top two products—Moov and Dettol—accounting for 15.3% of the total import value. This indicates a strategic focus on specific high-demand products within the over-the-counter (OTC) segment.

2Distribution Network

While specific details about Kathmandu Marketing AND Trading's warehouse locations and logistics capabilities are not publicly available, the company's substantial import volume suggests a well-established distribution network within Nepal. The 217 shipments indicate a consistent supply chain, likely supported by multiple warehouses to ensure timely delivery across the country. Given the high concentration of imports from Indian suppliers, the company likely maintains strong logistical ties with Indian manufacturers to facilitate efficient cross-border trade.

3Industry Role

Kathmandu Marketing AND Trading functions primarily as a pharmaceutical importer and buyer, sourcing finished pharmaceutical formulations from Indian suppliers. Its role is crucial in bridging the supply of pharmaceutical products from India to the Nepalese market, ensuring the availability of essential medicines. The company's focus on OTC products suggests a strategy aimed at meeting the immediate healthcare needs of the general population, positioning it as a key player in the retail pharmaceutical supply chain.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Kathmandu Marketing AND Trading

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

The company's sourcing strategy exhibits a high degree of concentration, with its top two products—Moov and Dettol—accounting for 15.3% of the total import value. This concentration indicates a strategic focus on specific high-demand products within the over-the-counter (OTC) segment. The reliance on a limited number of products may streamline operations and strengthen supplier relationships. However, this approach also exposes the company to risks associated with market fluctuations and changes in consumer preferences. Diversifying the product portfolio could mitigate such risks and enhance market resilience.

2Supply Chain Resilience

Kathmandu Marketing AND Trading's supply chain resilience is closely tied to its sourcing strategy. The company's dependence on a limited number of products and suppliers may pose challenges in the event of supply disruptions. The absence of publicly available information on backup suppliers and formulation diversity suggests potential vulnerabilities. To enhance resilience, the company could consider diversifying its supplier base and product portfolio, thereby reducing dependency on specific suppliers and formulations. Additionally, establishing contingency plans and maintaining strategic stock levels could further strengthen the supply chain against unforeseen disruptions.

Importing Pharmaceuticals into Nepal — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Nepal

1Regulatory Authority & Framework

In Nepal, the Department of Drug Administration (DDA) serves as the national regulatory authority for pharmaceuticals. Established in 1979 under the Drug Act 2035 (1978), the DDA is responsible for regulating the production, marketing, import, export, storage, supply, sale, and distribution of medicines and health technologies. The DDA enforces compliance with the Drug Act and formulates policies to facilitate access to pharmaceutical products. The Drug Act 2035 (1978) is the primary legislation governing pharmaceuticals in Nepal, providing the legal framework for the regulation of drugs, including their manufacture, import, export, sale, distribution, and quality control.

2Import Licensing & GMP

Importing pharmaceutical products into Nepal requires compliance with the Drug Act 2035 (1978) and obtaining the necessary licenses from the Department of Drug Administration (DDA). The foreign manufacturer must be registered with the DDA, and each drug product must have a valid drug registration certificate. The importer must obtain a DDA recommendation letter before securing an import license. Narcotic and psychotropic substances require special authorization coordinated with the International Narcotic Control Board. The National GMP Code 2072 (2015 A.D.) sets minimum Good Manufacturing Practice standards for pharmaceutical production in Nepal, covering premises, equipment, personnel, documentation, production processes, quality control, and storage. The DDA conducts GMP audits and certification to ensure compliance with these standards.

Kathmandu Marketing AND Trading — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

Kathmandu Marketing AND Trading's focus on over-the-counter (OTC) products, particularly Moov and Dettol, aligns with the high demand for accessible and effective healthcare solutions in Nepal. The choice of these specific therapeutic areas is likely driven by consumer preferences for topical analgesics and antiseptics, which are commonly used for pain relief and infection prevention. The company's import strategy appears to be responsive to market needs, aiming to provide essential healthcare products that are readily available to the general population.

2Sourcing Profile

Kathmandu Marketing AND Trading's sourcing strategy is centered on importing finished pharmaceutical formulations from Indian suppliers, with a particular emphasis on OTC products. The company's portfolio includes a diverse range of formulations, with 93 unique formulations imported. This diversity indicates a comprehensive approach to meeting various consumer needs within the OTC segment. India's established pharmaceutical manufacturing capabilities and competitive pricing make it a strategic sourcing partner for Kathmandu Marketing AND Trading.

3Market Positioning

Seller's Guide — How to Become a Supplier to Kathmandu Marketing AND Trading

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to partner with Kathmandu Marketing AND Trading. The company's existing relationships with Indian suppliers, such as Reckitt Benckiser India Private Limited, indicate a strong foundation for collaboration. However, the high concentration of imports in specific products suggests that Kathmandu Marketing AND Trading may be open to diversifying its product portfolio. Indian exporters can explore opportunities to introduce additional OTC products or alternative formulations to meet evolving consumer demands in Nepal.

2Requirements & Qualifications

Indian exporters seeking to supply Kathmandu Marketing AND Trading must ensure that their products are registered with the Department of Drug Administration (DDA) in Nepal. Compliance with the National GMP Code 2072 (2015 A.D.) is essential to meet the quality standards set by the DDA. Additionally, products must adhere to labeling requirements, including information in the Nepali language. Exporters should also be prepared to provide necessary documentation and certifications to facilitate the import licensing process.

3How to Approach

Frequently Asked Questions — Kathmandu Marketing AND Trading

What products does Kathmandu Marketing AND Trading import from India?

Kathmandu Marketing AND Trading imports 2 pharmaceutical products across 1 categories. Top imports: Moov ($1.1M), Dettol ($620.9K).

Who supplies pharmaceuticals to Kathmandu Marketing AND Trading from India?

Kathmandu Marketing AND Trading sources from 3 verified Indian suppliers. The primary supplier is Reckitt Benckiser (india) Private Limited (57.6% of imports, $1.7M).

What is Kathmandu Marketing AND Trading's total pharmaceutical import value?

Kathmandu Marketing AND Trading's total pharmaceutical import value from India is $1.7M, based on 217 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Kathmandu Marketing AND Trading focus on?

Kathmandu Marketing AND Trading imports across 1 categories. The largest: Brand Names & OTC Products (100.0%).

Get Full Kathmandu Marketing AND Trading Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. For current shipment-level data, contact TransData Nexus.